Literature DB >> 21267397

Surgical treatment of hepatic metastases from colorectal cancer.

Georgios Tsoulfas1, Manousos Georgios Pramateftakis, Ioannis Kanellos.   

Abstract

Colorectal carcinoma is one of the most frequent cancers in Western societies with an incidence of around 700 per million people. About half of the patients develop metastases from the primary tumor and liver is the primary metastatic site. Improved survival rates after hepatectomy for metastatic colorectal cancer have been reported in the last few years and these may be the result of a variety of factors, such as advances in systemic chemotherapy, radiographic imaging techniques that permit more accurate determination of the extent and location of the metastatic burden, local ablation methods, and in surgical techniques of hepatic resection. These have led to a more aggressive approach towards liver metastatic disease, resulting in longer survival. The goal of this paper is to review the role of various forms of surgery in the treatment of hepatic metastases from colorectal cancer.

Entities:  

Keywords:  Colorectal cancer; Hepatic metastases; Liver resection

Year:  2011        PMID: 21267397      PMCID: PMC3026051          DOI: 10.4251/wjgo.v3.i1.1

Source DB:  PubMed          Journal:  World J Gastrointest Oncol


  90 in total

1.  Liver resection after irinotecan, 5-fluorouracil, and folinic acid for patients with unresectable colorectal liver metastases: a multicenter phase II study by the Cancer Therapeutic Research Group.

Authors:  Wing M Ho; B Ma; Tony Mok; W Yeo; Paul Lai; R Lim; Jane Koh; Y Y Wong; Ann King; C K Leow; A T C Chan
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

2.  Longterm results and prognostic indicators after cryotherapy and hepatic arterial chemotherapy with or without resection for colorectal liver metastases in 224 patients: longterm survival can be achieved in patients with multiple bilateral liver metastases.

Authors:  Tristan D Yan; Ratnasari Padang; David L Morris
Journal:  J Am Coll Surg       Date:  2005-11-02       Impact factor: 6.113

3.  Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma.

Authors:  Shimul A Shah; Riad Haddad; Wigdan Al-Sukhni; Robin D Kim; Paul D Greig; David R Grant; Bryce R Taylor; Bernard Langer; Steven Gallinger; Alice C Wei
Journal:  J Am Coll Surg       Date:  2006-01-18       Impact factor: 6.113

4.  Value of carcinoembryonic antigen assay in predicting hepatic metastases, local recurrence, and survival after curative resection of colorectal cancer.

Authors:  Ioannis Kanellos; Emmanouil Zacharakis; Haralampos Demetriades; Emmanouil Christoforidis; Dimitrios Kanellos; Manousos-Georgios Pramateftakis; Dimitrios Betsis
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

5.  Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases.

Authors:  Timothy M Pawlik; Charles R Scoggins; Daria Zorzi; Eddie K Abdalla; Axel Andres; Cathy Eng; Steven A Curley; Evelyne M Loyer; Andrea Muratore; Gilles Mentha; Lorenzo Capussotti; Jean-Nicolas Vauthey
Journal:  Ann Surg       Date:  2005-05       Impact factor: 12.969

6.  OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer.

Authors:  Graeme J Poston; René Adam; Steven Alberts; Steven Curley; Juan Figueras; Daniel Haller; Francis Kunstlinger; Gilles Mentha; Bernard Nordlinger; Yehuda Patt; John Primrose; Mark Roh; Philippe Rougier; Theo Ruers; Hans Joachim Schmoll; Carlos Valls; Nick Jean-Nicolas Vauthey; Marleen Cornelis; James P Kahan
Journal:  J Clin Oncol       Date:  2005-10-01       Impact factor: 44.544

7.  Genetic detection of lymph node micrometastases: a selection criterion for liver transplantation in patients with liver metastases after colorectal cancer.

Authors:  Sonja Kappel; Daniela Kandioler; Rudolf Steininger; Friedrich Längle; Friedrich Wrba; Martin Ploder; Gabriela Berlakovich; Thomas Soliman; Hubert Hetz; Susanne Rockenschaub; Erich Roth; Ferdinand Mühlbacher
Journal:  Transplantation       Date:  2006-01-15       Impact factor: 4.939

8.  Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary.

Authors:  G Mentha; P E Majno; A Andres; L Rubbia-Brandt; P Morel; A D Roth
Journal:  Br J Surg       Date:  2006-07       Impact factor: 6.939

9.  Resection margin in patients undergoing hepatectomy for colorectal liver metastasis: a critical appraisal of the 1cm rule.

Authors:  Z Z R Hamady; I C Cameron; J Wyatt; R K Prasad; G J Toogood; J P A Lodge
Journal:  Eur J Surg Oncol       Date:  2006-04-03       Impact factor: 4.424

10.  Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases.

Authors:  Reza Kianmanesh; Stefano Scaringi; Jean-Marc Sabate; Benjamin Castel; Nathalie Pons-Kerjean; Benoit Coffin; Jean-Marie Hay; Yves Flamant; Simon Msika
Journal:  Ann Surg       Date:  2007-04       Impact factor: 12.969

View more
  7 in total

Review 1.  A Concise Review of Pelvic Radiation Therapy (RT) for Rectal Cancer with Synchronous Liver Metastases.

Authors:  Omer Sager; Ferrat Dincoglan; Selcuk Demiral; Bora Uysal; Hakan Gamsiz; Bahar Dirican; Murat Beyzadeoglu
Journal:  Int J Surg Oncol       Date:  2019-04-21

2.  The efficient circulating immunoscore predicts prognosis of patients with advanced gastrointestinal cancer.

Authors:  Yamei Zhao; Yan Tang; Hanlin Qin; Kehai Feng; Changlu Hu
Journal:  World J Surg Oncol       Date:  2022-07-12       Impact factor: 3.253

3.  Focused abdominal ultrasound in preoperative liver surgery staging: a prospective study.

Authors:  Marcela P Cohen; Paulo Herman; Rubens Chojniak; Miriam R B Poli; Paula N V Barbosa; Almir G V Bitencourt
Journal:  World J Surg Oncol       Date:  2013-06-14       Impact factor: 2.754

4.  Brain metastasis in pancreatic cancer.

Authors:  Johannes Lemke; Jan Scheele; Thomas Kapapa; Christian Rainer Wirtz; Doris Henne-Bruns; Marko Kornmann
Journal:  Int J Mol Sci       Date:  2013-02-19       Impact factor: 5.923

5.  Galla Rhois water extract inhibits lung metastasis by inducing AMPK‑mediated apoptosis and suppressing metastatic properties of colorectal cancer cells.

Authors:  Jeong-Geon Mun; Ji-Ye Kee; Yo-Han Han; Sullim Lee; Seong-Hwan Park; Hee Dong Jeon; Seung-Heon Hong
Journal:  Oncol Rep       Date:  2018-10-22       Impact factor: 3.906

6.  The Cuban Propolis Component Nemorosone Inhibits Proliferation and Metastatic Properties of Human Colorectal Cancer Cells.

Authors:  Yahima Frión-Herrera; Daniela Gabbia; Michela Scaffidi; Letizia Zagni; Osmany Cuesta-Rubio; Sara De Martin; Maria Carrara
Journal:  Int J Mol Sci       Date:  2020-03-06       Impact factor: 5.923

7.  Preparation and In Vitro Evaluation of Neutron-Activated, Theranostic Samarium-153-Labeled Microspheres for Transarterial Radioembolization of Hepatocellular Carcinoma and Liver Metastasis.

Authors:  Yin How Wong; Hun Yee Tan; Azahari Kasbollah; Basri Johan Jeet Abdullah; Chai Hong Yeong
Journal:  Pharmaceutics       Date:  2019-11-12       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.